Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.030
-0.060 (-1.94%)
Aug 14, 2025, 11:32 AM - Market open
Rocket Pharmaceuticals Employees
Rocket Pharmaceuticals had 299 employees as of December 31, 2024. The number of employees increased by 31 or 11.57% compared to the previous year.
Employees
299
Change (1Y)
31
Growth (1Y)
11.57%
Revenue / Employee
n/a
Profits / Employee
-$860,532
Market Cap
326.95M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
RCKT News
- 5 days ago - DEADLINE NEXT WEEK: Berger Montague Advises Rocket Pharmaceuticals (NASDAQ: RCKT) Investors to Contact the Firm Before August 11, 2025 - PRNewsWire
- 6 days ago - Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress - Business Wire
- 14 days ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals - GlobeNewsWire
- 15 days ago - What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday? - Benzinga
- 16 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals - PRNewsWire
- 19 days ago - Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours - Benzinga
- 20 days ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Pharmaceuticals, Inc. Lawsuit – RCKT - GlobeNewsWire
- 21 days ago - Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs - Business Wire